Company: BPAC
Filing Date: 2025-10-22
Form Type: S-1/A
Source: 0001185185-25-001525
Chunk: 138

Company: Blueport Acquisition Ltd
Filing Date: 2025-10-22
Form: S-1/A
Chunk 138
---
 their public shares to us by means of a tender offer (and
thereby avoid the need for a shareholder vote) for an amount equal to their pro rata share of the aggregate amount then on deposit in
the trust account (net of taxes payable), in each case subject to the limitations described herein. Notwithstanding the foregoing, our
initial shareholders will agree, pursuant to written letter agreements with us, not to convert any public shares held by them into their
pro rata share of the aggregate amount then on deposit in the trust account. If we determine to engage in a tender offer, such tender
offer will be structured so that each shareholder may tender any or all of his, her or its public shares rather than some pro rata portion
of his, her or its shares. The decision as to whether we will seek shareholder approval of a proposed business combination or will allow
shareholders to sell their shares to us in a tender offer will be made by us based on a variety of factors such as the timing of the transaction,
or whether the terms of the transaction would otherwise require us to seek shareholder approval. If we so choose and we are legally permitted
to do so, we have the flexibility to avoid a shareholder vote and allow our shareholders to sell their shares pursuant to Rule 13e-4 and
Regulation 14E of the Exchange Act which regulate issuer tender offers. In that case, we will file tender offer documents with the SEC
which will contain substantially the same financial and other information about the initial business combination as is required under
the SEC’s proxy rules.

<div align='center'>81</div>

Our initial shareholders and our
officers and directors have agreed (1) vote any initial shares and private shares held by them and any public shares purchased during
or after this offering (including in open market and privately-negotiated transactions, aside from shares they may purchase in compliance
with the requirements of Rule 14e-5 under the Exchange Act, which would not be voted in favor of approving our initial business combination,
(2) not to convert any ordinary shares in connection with a shareholder vote to approve a proposed initial business combination, and (3)
not sell any ordinary shares in any tender in connection with a proposed initial business combination.

As a result, if we sought shareholder
approval of a proposed transaction, which would require a simple majority of votes (assuming the underwriters do not exercise their over-allotment
option), we could need as little 1,782,001 of